![Jay Stout](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 8 M $ al 31/07/2026
Jay S.
Stout is currently Chief Technology Officer at Immunovant, Inc. since 2023.
Formerly, Dr. Stout was Chief Technical Officer at Immunomedics, Inc. and Senior Vice President-Technical Operations at Versartis, Inc. Education includes undergraduate and graduate degrees from the University of Iowa and a doctorate from The University of Nebraska-Lincoln.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUNOVANT INC 0,1 % | 23/07/2026 | 205.341 ( 0,1 % ) | 8 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNOVANT, INC. | Director Técnico/Científico/I+D | 01/04/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| IMMUNOMEDICS, INC. | Director Técnico/Científico/I+D | - |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
The University of Nebraska-Lincoln
 The University of Nebraska-Lincoln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
